The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review
Fengcui Sun,1 Xiufen Yang,1 Chaoqun Ma,1 Shizhao Zhang,1 Lu Yu,2 Haifei Lu,3 Guoliang Yin,1 Pengpeng Liang,1 Yanan Feng,1 Fengxia Zhang4 1Shandong University of Traditional Chinese Medicine, Jinan, 250000, People’s Republic of China; 2Tianjin University of Traditional Chinese Medicine, Tianjin, 3016...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/13519f308cba4135a0ad377b946e5373 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:13519f308cba4135a0ad377b946e5373 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:13519f308cba4135a0ad377b946e53732021-12-02T18:03:14ZThe Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review1178-7007https://doaj.org/article/13519f308cba4135a0ad377b946e53732021-09-01T00:00:00Zhttps://www.dovepress.com/the-effects-of-diosgenin-on-hypolipidemia-and-its-underlying-mechanism-peer-reviewed-fulltext-article-DMSOhttps://doaj.org/toc/1178-7007Fengcui Sun,1 Xiufen Yang,1 Chaoqun Ma,1 Shizhao Zhang,1 Lu Yu,2 Haifei Lu,3 Guoliang Yin,1 Pengpeng Liang,1 Yanan Feng,1 Fengxia Zhang4 1Shandong University of Traditional Chinese Medicine, Jinan, 250000, People’s Republic of China; 2Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, People’s Republic of China; 3Hubei University of Traditional Chinese Medicine, Wuhan, 430065, People’s Republic of China; 4Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250011, People’s Republic of ChinaCorrespondence: Fengxia ZhangDepartment of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250011, People’s Republic of ChinaTel +8653168616011Email fxzhang0987@163.comAbstract: Hyperlipidemia is a disorder of lipid metabolism, which is a major cause of coronary heart disease. Although there has been considerable progress in hyperlipidemia treatment, morbidity and risk associated with the condition continue to rise. The first-line treatment for hyperlipidemia, statins, has multiple side effects; therefore, development of safe and effective drugs from natural products to prevent and treat hyperlipidemia is necessary. Diosgenin is primarily derived from fenugreek (Trigonella foenum graecum) seeds, and is also abundant in medicinal herbs such as Dioscorea rhizome, Dioscorea septemloba, and Rhizoma polygonati, is a well-known steroidal sapogenin and the active ingredient in many drugs to treat cardiovascular conditions. There is abundant evidence that diosgenin has potential for application in correcting lipid metabolism disorders. In this review, we evaluated the latest evidence related to diosgenin and hyperlipidemia from clinical and animal studies. Additionally, we elaborate the pharmacological mechanism underlying the activity of diosgenin in treating hyperlipidemia in detail, including its role in inhibition of intestinal absorption of lipids, regulation of cholesterol transport, promotion of cholesterol conversion into bile acid and its excretion, inhibition of endogenous lipid biosynthesis, antioxidation and lipoprotein lipase activity, and regulation of transcription factors related to lipid metabolism. This review provides a deep exploration of the pharmacological mechanisms involved in diosgenin-hyperlipidemia interactions and suggests potential routes for the development of novel drug therapies for hyperlipidemia.Keywords: diosgenin, hyperlipidemia, serum cholesterol, lipoprotein cholesterol, mechanismSun FYang XMa CZhang SYu LLu HYin GLiang PFeng YZhang FDove Medical Pressarticlediosgeninhyperlipidemiaserum cholesterollipoprotein cholesterolmechanismSpecialties of internal medicineRC581-951ENDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol Volume 14, Pp 4015-4030 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
diosgenin hyperlipidemia serum cholesterol lipoprotein cholesterol mechanism Specialties of internal medicine RC581-951 |
| spellingShingle |
diosgenin hyperlipidemia serum cholesterol lipoprotein cholesterol mechanism Specialties of internal medicine RC581-951 Sun F Yang X Ma C Zhang S Yu L Lu H Yin G Liang P Feng Y Zhang F The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review |
| description |
Fengcui Sun,1 Xiufen Yang,1 Chaoqun Ma,1 Shizhao Zhang,1 Lu Yu,2 Haifei Lu,3 Guoliang Yin,1 Pengpeng Liang,1 Yanan Feng,1 Fengxia Zhang4 1Shandong University of Traditional Chinese Medicine, Jinan, 250000, People’s Republic of China; 2Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, People’s Republic of China; 3Hubei University of Traditional Chinese Medicine, Wuhan, 430065, People’s Republic of China; 4Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250011, People’s Republic of ChinaCorrespondence: Fengxia ZhangDepartment of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, 250011, People’s Republic of ChinaTel +8653168616011Email fxzhang0987@163.comAbstract: Hyperlipidemia is a disorder of lipid metabolism, which is a major cause of coronary heart disease. Although there has been considerable progress in hyperlipidemia treatment, morbidity and risk associated with the condition continue to rise. The first-line treatment for hyperlipidemia, statins, has multiple side effects; therefore, development of safe and effective drugs from natural products to prevent and treat hyperlipidemia is necessary. Diosgenin is primarily derived from fenugreek (Trigonella foenum graecum) seeds, and is also abundant in medicinal herbs such as Dioscorea rhizome, Dioscorea septemloba, and Rhizoma polygonati, is a well-known steroidal sapogenin and the active ingredient in many drugs to treat cardiovascular conditions. There is abundant evidence that diosgenin has potential for application in correcting lipid metabolism disorders. In this review, we evaluated the latest evidence related to diosgenin and hyperlipidemia from clinical and animal studies. Additionally, we elaborate the pharmacological mechanism underlying the activity of diosgenin in treating hyperlipidemia in detail, including its role in inhibition of intestinal absorption of lipids, regulation of cholesterol transport, promotion of cholesterol conversion into bile acid and its excretion, inhibition of endogenous lipid biosynthesis, antioxidation and lipoprotein lipase activity, and regulation of transcription factors related to lipid metabolism. This review provides a deep exploration of the pharmacological mechanisms involved in diosgenin-hyperlipidemia interactions and suggests potential routes for the development of novel drug therapies for hyperlipidemia.Keywords: diosgenin, hyperlipidemia, serum cholesterol, lipoprotein cholesterol, mechanism |
| format |
article |
| author |
Sun F Yang X Ma C Zhang S Yu L Lu H Yin G Liang P Feng Y Zhang F |
| author_facet |
Sun F Yang X Ma C Zhang S Yu L Lu H Yin G Liang P Feng Y Zhang F |
| author_sort |
Sun F |
| title |
The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review |
| title_short |
The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review |
| title_full |
The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review |
| title_fullStr |
The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review |
| title_full_unstemmed |
The Effects of Diosgenin on Hypolipidemia and Its Underlying Mechanism: A Review |
| title_sort |
effects of diosgenin on hypolipidemia and its underlying mechanism: a review |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/13519f308cba4135a0ad377b946e5373 |
| work_keys_str_mv |
AT sunf theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT yangx theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT mac theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT zhangs theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT yul theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT luh theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT ying theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT liangp theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT fengy theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT zhangf theeffectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT sunf effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT yangx effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT mac effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT zhangs effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT yul effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT luh effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT ying effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT liangp effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT fengy effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview AT zhangf effectsofdiosgeninonhypolipidemiaanditsunderlyingmechanismareview |
| _version_ |
1718378792481718272 |